Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2014 | 1 |
2016 | 3 |
2022 | 1 |
2024 | 1 |
Search Results
6 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Did you mean
tummler b[au]
(358 results)?
Helicase-primase inhibitor pritelivir for HSV-2 infection.
N Engl J Med. 2014 Jan 16;370(3):201-10. doi: 10.1056/NEJMoa1301150.
N Engl J Med. 2014.
PMID: 24428466
Free article.
Clinical Trial.
Discovery, Chemistry, and Preclinical Development of Pritelivir, a Novel Treatment Option for Acyclovir-Resistant Herpes Simplex Virus Infections.
Birkmann A, Bonsmann S, Kropeit D, Pfaff T, Rangaraju M, Sumner M, Timmler B, Zimmermann H, Buschmann H, Ruebsamen-Schaeff H.
Birkmann A, et al. Among authors: timmler b.
J Med Chem. 2022 Oct 27;65(20):13614-13628. doi: 10.1021/acs.jmedchem.2c00668. Epub 2022 Oct 6.
J Med Chem. 2022.
PMID: 36202389
Free PMC article.
Item in Clipboard
Mathematical modeling of herpes simplex virus-2 suppression with pritelivir predicts trial outcomes.
Schiffer JT, Swan DA, Magaret A, Corey L, Wald A, Ossig J, Ruebsamen-Schaeff H, Stoelben S, Timmler B, Zimmermann H, Melhem MR, Van Wart SA, Rubino CM, Birkmann A.
Schiffer JT, et al. Among authors: timmler b.
Sci Transl Med. 2016 Feb 3;8(324):324ra15. doi: 10.1126/scitranslmed.aad6654.
Sci Transl Med. 2016.
PMID: 26843190
Free PMC article.
Item in Clipboard
A Multicenter Assessment of the Outcomes and Toxicities of Foscarnet for Treatment of Acyclovir-Resistant Mucocutaneous Herpes Simplex in Immunocompromised Patients.
Hammond SP, Rangaraju M, Sumner M, Timmler B, Chandrasekar P, Avery RK.
Hammond SP, et al. Among authors: timmler b.
Open Forum Infect Dis. 2024 Feb 5;11(3):ofae046. doi: 10.1093/ofid/ofae046. eCollection 2024 Mar.
Open Forum Infect Dis. 2024.
PMID: 38444818
Free PMC article.
Item in Clipboard
Effect of Pritelivir Compared With Valacyclovir on Genital HSV-2 Shedding in Patients With Frequent Recurrences: A Randomized Clinical Trial.
Wald A, Timmler B, Magaret A, Warren T, Tyring S, Johnston C, Fife K, Selke S, Huang ML, Stobernack HP, Zimmermann H, Corey L, Birkmann A, Ruebsamen-Schaeff H.
Wald A, et al. Among authors: timmler b.
JAMA. 2016 Dec 20;316(23):2495-2503. doi: 10.1001/jama.2016.18189.
JAMA. 2016.
PMID: 27997653
Clinical Trial.
Item in Clipboard
No Evidence of Pritelivir Resistance Among Herpes Simplex Virus Type 2 Isolates After 4 Weeks of Daily Therapy.
Edlefsen PT, Birkmann A, Huang ML, Magaret CA, Kee JJ, Diem K, Goldner T, Timmler B, Stoelben S, Ruebsamen-Schaeff H, Zimmermann H, Warren T, Wald A, Corey L.
Edlefsen PT, et al. Among authors: timmler b.
J Infect Dis. 2016 Jul 15;214(2):258-64. doi: 10.1093/infdis/jiw129. Epub 2016 Apr 7.
J Infect Dis. 2016.
PMID: 27056950
Free PMC article.
Clinical Trial.
Item in Clipboard
Cite
Cite